Home Impurity Olmesartan CS-T-62582

Olmesartan N2-Trityl Impurity

Impurity API Family: Olmesartan CAT No. CS-T-62582 CAS No. 752179-89-8
In Stock
Product Detail

Olmesartan N2-Trityl Impurity

Olmesartan Impurity
Stock Status: In Stock  Login to view price
Live
For Research & Analytical Purposes. Not for Personal use.
Category Impurity
API Family Olmesartan
Storage Store at refrigerator (2-8°C) for long term storage
Hazard Information Refer MSDS for accurate information.

Olmesartan N2-Trityl Impurity Product Information

Olmesartan N2-Trityl Impurity is listed under Impurity. It is associated with Olmesartan and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-62582.

Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.

Technical Data

Product Name
Olmesartan N2-Trityl Impurity
CAS No.
752179-89-8
CAT No.
CS-T-62582
Molecular Formula
C₄₃H₄₀N₆O₃
Molecular Weight
688.32
Category
API Family
Storage Condition
Store at refrigerator (2-8°C) for long term storage
IUPAC Name
4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(2-trityl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-carboxylic acid
Purity by HPLC
98.28%
Hazard Compound
Refer MSDS for accurate information.

Description

Overview
N2-Trityl Olmesartan Acid is an intermediate in the synthesis of Olmesartan medoxomil related compounds.
Synonyms
Not available
Application Notes
N2-Trityl Olmesartan Acid is an intermediate in the synthesis of Olmesartan medoxomil related compounds.
References
"Yanagisawa, H,, et al,: J, Med, Chem,, 39, 323 (1996), Puchler, K,, et al,: J, Hypertens,, 15, 1809 (1997)"
Downloading MSDS…
Done
Done
RFQ Basket 0
Done
RFQ Basket 0
Quick Enquiry
Tell us what you need
Quote Basket
Selected RFQ Items
Your RFQ basket is empty. Add a product block or copy a guided requirement here.